Items tagged with Treatment
After contact with a teacher diagnosed with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection, according to recent study results published in The Pediatric Infectious Disease Journal.
TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product development, today announced it has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop quantitative mathematical models to optimize the design of clinical trials and tackle challenges facing the development of effective tuberculosis (TB) treatments.
Three quarters of South African patients with extensively drug-resistant (XDR) tuberculosis died within 5 years of treatment, according to results of a 107-patient analysis in three South African provinces. Among people with HIV infection, taking antiretroviral therapy (ART) was independently associated with survival.
People being treated for tuberculosis achieved virologic and CD4 responses to antiretroviral therapy (ART) similar to people not being treated for TB, according to results of a 25-study systematic review and meta-analysis.
Patients who have multi-drug-resistant tuberculosis andare more likely to live if they get simultaneous treatment for both diseases rather than waiting weeks to start the AIDS treatment, a new study has found.
Virologic response at 48 weeks was similar with 400 mg of efavirenz daily and the standard 600 mg daily in a double-blind randomized trial involving antiretroviral-naive people in 13 countries across the world. Safety was better with the lower dose.
Phakama Clinic is one of the 23 urban clinics supported since 2012 through The Union’s TB CARE project in 17 urban areas of Zimbabwe. Located in a high-density suburb of the City of Gwanda, provincial capital of Matabeleland South Province, Phakama Clinic is the only one participating in the project that is run by the local authority.
Cape Town - Local tuberculosis experts are optimistic that a novel TB antibiotic, which is being tested on multidrug-resistant TB sufferers in a Cape Town hospital, could revolutionise treatment of the killer disease.
BOSTON — A shorter treatment regimen consisting of rifapentine, moxifloxacin, isoniazid and pyrazinamide was more active than a control regimen against drug-susceptible pulmonary tuberculosis, researchers reported at the 2014 Conference on Retroviruses and Opportunistic Infections.
Page 2 of 103 · Total posts: 0←First 1 2 3 Last→